These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33314293)

  • 21. 3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease.
    Ogisu K; Kudo K; Sasaki M; Sakushima K; Yabe I; Sasaki H; Terae S; Nakanishi M; Shirato H
    Neuroradiology; 2013 Jun; 55(6):719-24. PubMed ID: 23525598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo detection of substantia nigra and locus coeruleus volume loss in Parkinson's disease using neuromelanin-sensitive MRI: Replication in two cohorts.
    Hwang KS; Langley J; Tripathi R; Hu XP; Huddleston DE
    PLoS One; 2023; 18(4):e0282684. PubMed ID: 37053195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early-stage Parkinson's disease: Abnormal nigrosome 1 and 2 revealed by a voxelwise analysis of neuromelanin-sensitive MRI.
    Sung YH; Noh Y; Kim EY
    Hum Brain Mapp; 2021 Jun; 42(9):2823-2832. PubMed ID: 33751680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MRI T
    Lee H; Baek SY; Kim EJ; Huh GY; Lee JH; Cho H
    Neuroimage; 2020 May; 211():116625. PubMed ID: 32058001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multimodal assessment of nigrosomal degeneration in Parkinson's disease.
    Langley J; Huddleston DE; Crosson B; Song DD; Factor SA; Hu X
    Parkinsonism Relat Disord; 2020 Nov; 80():102-107. PubMed ID: 32979784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Short-echo-time magnitude image derived from quantitative susceptibility mapping could resemble neuromelanin-sensitive MRI image in substantia nigra.
    Liu XL; Yang LQ; Liu FT; Wu PY; Zhang Y; Zhuang H; Shi YH; Wang J; Geng DY; Li YX
    BMC Neurol; 2020 Jun; 20(1):262. PubMed ID: 32605601
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
    Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Azevedo P; Ferreira J; Abreu D; Gonçalves N; Nunes RG; Campos J; Ferreira JJ
    Mov Disord; 2015 Jun; 30(7):953-9. PubMed ID: 25758364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Assessment of Brainstem Depigmentation in Parkinson Disease: Potential as a Severity Marker for Multicenter Studies.
    Schwarz ST; Xing Y; Tomar P; Bajaj N; Auer DP
    Radiology; 2017 Jun; 283(3):789-798. PubMed ID: 27820685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multimodal Imaging of Substantia Nigra in Parkinson's Disease with Levodopa-Induced Dyskinesia.
    Su D; Gan Y; Zhang Z; Cui Y; Zhang Z; Liu Z; Wang Z; Zhou J; Sossi V; Stoessl AJ; Wu T; Jing J; Feng T
    Mov Disord; 2023 Apr; 38(4):616-625. PubMed ID: 36799459
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T2-Weighted intracranial vessel wall imaging at 7 Tesla using a DANTE-prepared variable flip angle turbo spin echo readout (DANTE-SPACE).
    Viessmann O; Li L; Benjamin P; Jezzard P
    Magn Reson Med; 2017 Feb; 77(2):655-663. PubMed ID: 26890988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence.
    Liu Y; Li J; He N; Chen Y; Jin Z; Yan F; Haacke EM
    Neuroimage; 2020 Sep; 218():116935. PubMed ID: 32413460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease.
    Sasaki M; Shibata E; Tohyama K; Takahashi J; Otsuka K; Tsuchiya K; Takahashi S; Ehara S; Terayama Y; Sakai A
    Neuroreport; 2006 Jul; 17(11):1215-8. PubMed ID: 16837857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Automatic detection of neuromelanin and iron in the midbrain nuclei using a magnetic resonance imaging-based brain template.
    Jin Z; Wang Y; Jokar M; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Zhang Y; Min J; Liu F; He N; Yan F; Haacke EM
    Hum Brain Mapp; 2022 Apr; 43(6):2011-2025. PubMed ID: 35072301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative Study of MRI Biomarkers in the Substantia Nigra to Discriminate Idiopathic Parkinson Disease.
    Pyatigorskaya N; Magnin B; Mongin M; Yahia-Cherif L; Valabregue R; Arnaldi D; Ewenczyk C; Poupon C; Vidailhet M; Lehéricy S
    AJNR Am J Neuroradiol; 2018 Aug; 39(8):1460-1467. PubMed ID: 29954816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromelanin imaging and midbrain volumetry in progressive supranuclear palsy and Parkinson's disease.
    Taniguchi D; Hatano T; Kamagata K; Okuzumi A; Oji Y; Mori A; Hori M; Aoki S; Hattori N
    Mov Disord; 2018 Sep; 33(9):1488-1492. PubMed ID: 29756366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report.
    Ishikuro K; Hattori N; Imanishi R; Furuya K; Nakata T; Dougu N; Yamamoto M; Konishi H; Nukui T; Hayashi T; Anada R; Matsuda N; Hirosawa H; Tanaka R; Shibata T; Mori K; Noguchi K; Kuroda S; Nakatsuji Y; Nishijo H
    Neurocase; 2021 Oct; 27(5):407-414. PubMed ID: 34503372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution magnetic resonance imaging of intracranial vessel walls: Comparison of 3D T1-weighted turbo spin echo with or without DANTE or iMSDE.
    Cho SJ; Jung SC; Suh CH; Lee JB; Kim D
    PLoS One; 2019; 14(8):e0220603. PubMed ID: 31386679
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diagnostic value of SNpc using NM-MRI in Parkinson's disease: meta-analysis.
    Wang X; Zhang Y; Zhu C; Li G; Kang J; Chen F; Yang L
    Neurol Sci; 2019 Dec; 40(12):2479-2489. PubMed ID: 31392640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
    Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
    Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.